XML 38 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating expenses      
Research and development $ 18,381 $ 16,977 $ 6,334
General and administrative 7,078 11,556 6,033
Total operating expenses 25,459 28,533 12,367
Financing expense (income), net (1,238) (353) 111
Loss before taxes 24,221 28,180 12,478
Tax benefit 0 (534) 0
Net loss for the year $ 24,221 $ 27,646 $ 12,478
Basic loss per Ordinary Share $ 0.103 $ 0.121 $ 0.06
Diluted loss per Ordinary Share $ 0.103 $ 0.121 $ 0.06
Weighted average number of Ordinary Shares outstanding, basic [1] 234,998,859 227,589,288 207,468,650
Weighted average number of Ordinary Shares outstanding, diluted [1] 234,998,859 227,589,288 207,468,650
[1] Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1)